Chris Herrera
Medical School: Perelman School of Medicine at the University of Pennsylvania Undergraduate: Carnegie Mellon University

About Dr. Herrera

Chris graduated from Carnegie Mellon University in 2016 with a B.S. in Civil Engineering, his pre-medical studies at Goucher College in 2017 and from the University of Pennsylvania Perelman School of Medicine in 2022. He obtained at Masters in Health Policy Research at Penn in 2022 with a focus on financial toxicity in prostate cancer survivorship and surgical access to care. He has also done work as a lead patient navigator at the Center for Surgical Health and Puentes de Salud Liaison, providing access to underserved Latinx communities in surgical care. Chris looks forward to continuing involvement with Puentes de Salud as a resident and further engaging underserved communities in Philadelphia. Chris is excited to explore the fields within Urology.

Education

2020 – 2022
MSHP (Masters in Health Policy Research)
Perelman School of Medicine at the University of Pennsylvania

Societies

  • American Urological Association

Awards / Honors

2021
Leonard Davis Institute Associate Fellow

2020 – 2021
David A. Asch Masters of Science Health Policy Research Scholarship

2020
MSHPR Medical Student Award in Community Engagement & Health Equity Research

2018

Agnew Summer Fellow in Global Surgery – Perelman School of Medicine

Research

Dr. Herrera’s research interests are rooted in increasing access to urological care through health services research and quality improvement. Through his research, he would love to decrease the direct and indirect financial burdens of urologic cancers and procedures and improve patient education.

Publications

Abstracts

  1. Herrera, C., Guerra, C., Narayan, V., Guzzo, T., Mamtani, R., Lee, D.J., Tasian, G., Talwar, R. MP1-09 Financial toxicity of prostate cancer survivorship: a national cross-sectional assessment of indirect financial burden. Canadian Journal of Urology, 2021; 28(Supplement 3).
  2. Talwar, R., Sperling, C., Xia L., Herrera, C. Parikh, R., Lee D., Guzzo T., Mamtani, R. MP4-06 Physicians’ Knowledge About Pembrolizumab for High-Risk Non-Muscle Invasive Bladder Cancer: Quality Improvement Targets in Multidisciplinary Cancer Care. Canadian Journal of Urology, 2021; 28(Supplement 3).
  3. Herrera C, Guerra C, Narayan V, et al. MP17-18 Financial burden of prostate cancer survivorship: a national cross-sectional assessment of subjective financial distress. Journal of Urology. 2021;206(Supplement 3). doi:10.1097/JU.0000000000002002.18

Peer-reviewed

  1. *Gualy, S., *Herrera, C., Warden, C. et al. Enabling Community Health Worker Recognition and Referral of Surgical Diseases:
    Pilot Study Results of a Pictorial Guide. World J Surg 43, 2949–2958 (2019)
Share This Page: